t-BOOH-induced oxidative damage in sickle red blood cells and the role of flavonoids.
Sickle cell anemia is a genetic disease characterized byan increase in generation of reactive oxygen species, abnormal iron release and low antioxidant activity which can lead to cell injury. Several therapies have been used to decrease the oxidative damage in these patients. In this study, we investigated the effect of flavonoids (quercetin and rutin) on the oxidation of red blood cells (RBC) from sickle cell anemia patients following exposure of the cells to tert-butyl hydroperoxide (t-BOOH). Quercetin provided greater protection against Hb oxidation, the binding of Hb to membrane and lipid peroxidation than did rutin. Quercetin (150 microM) reduced Hb oxidation by 30% and increased the level of oxyHb from 17.5 to 29 microM. Rutin prevented Hb oxidation only at concentrations higher than 200 microM and did not prevent the binding of Hb to RBC membrane. These distinct effects of the flavonoids probably reflect their structural characteristics. Thus, quercetin, which possesses a suitable structure for free-radical scavenging and ion quelation, was a more effective antioxidant than rutin. The presence of rutinose at position C(3) in rutin may impair its antioxidant effect. The presence of ascorbic acid enhanced the protective effect of quercetin and rutin against oxidative stress in sickle Hb and lipid peroxidation. This synergistic action helped to maintain a constant supply of flavonoids and thus, rescue the cells from the injury caused by free radicals and iron ions.
Cesquini
M
M
Departamento de Bioquímica, Instituto de Biologia, Universidade Estadual de Campinas (UNICAMP), CP 6109, CEP 13083-970, Campinas, SP, Brazil. cesquini@unicamp.br
Torsoni
M A
MA
Stoppa
G R
GR
Ogo
S H
SH
D000755:Anemia, Sickle Cell / Q000097:blood*; D000975:Antioxidants / Q000494:pharmacology*; D000986:Antisickling Agents / Q000494:pharmacology; D001803:Blood Transfusion; D004912:Erythrocytes / Q000187:drug effects*; D005419:Flavonoids / Q000494:pharmacology*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D015227:Lipid Peroxidation / Q000187:drug effects; D016877:Oxidants / Q000633:toxicity; D010084:Oxidation-Reduction; D018384:Oxidative Stress / Q000187:drug effects*; D011794:Quercetin / Q000494:pharmacology; D012431:Rutin / Q000494:pharmacology; D020122:tert-Butylhydroperoxide / Q000633:toxicity*
D000975:Antioxidants; D000986:Antisickling Agents; D005419:Flavonoids; D006454:Hemoglobins; D016877:Oxidants; D012431:Rutin; D020122:tert-Butylhydroperoxide; D011794:Quercetin